In summary, our novel method to detect the G17V RHOA mutation could provide an important clinical tool to diagnose AITL and AITL-like PTCL-NOS and in the future serve as a means to classify AITL and PTCL-NOS. This evidence concerns the gene RHOA and angioimmunoblastic T-cell lymphoma.